• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Diagnosis

Receiving a diagnosis of ALS/MND is a life-changing moment. This page explains what the diagnostic process typically involves and what people can expect in terms of how the disease progresses. It is intended as a general introduction. A neurologist or specialist will be the most important source of information for any individual situation.

How ALS/MND is diagnosed

There is no single test that confirms ALS/MND. Diagnosis is a process, and it can take time. A neurologist will typically conduct a series of assessments to identify signs of ALS/MND and to rule out other conditions that can cause similar symptoms.

The diagnostic process may include:

  • A detailed neurological examination to assess muscle strength, reflexes, coordination, and speech
  • Electromyography (EMG) and nerve conduction studies, which measure the electrical activity of muscles and nerves
  • MRI scans, to rule out other causes of symptoms such as spinal cord compression or stroke
  • Blood and urine tests, to exclude other conditions
  • In some cases, a muscle or nerve biopsy, or a lumbar puncture

Because ALS/MND shares some features with other neurological conditions, reaching a confirmed diagnosis can require multiple appointments and tests over a period of weeks or months. A second opinion from another specialist is a reasonable step, and many people find it helpful.

Once a diagnosis is confirmed, care is typically transferred to, or coordinated with, a multidisciplinary team. This team may include neurologists, physiotherapists, occupational therapists, speech therapists, respiratory specialists, dietitians, social workers, and others. For more on the care team and what it involves, see the Clinical Care section.

How ALS/MND progresses

ALS/MND affects each person differently. The rate and pattern of progression vary from one individual to the next, depending on factors such as which muscles are affected first, age at diagnosis, and overall health.

In most cases, ALS/MND begins with weakness or changes in one area — such as a hand, foot, or the muscles used for speaking or swallowing — and spreads over time to other parts of the body. The muscles that control breathing are typically affected as the disease progresses.

Cognitive and behavioural changes can also occur in some people living with ALS/MND, including difficulties with memory, language, or behaviour. These changes are more common in people who also have frontotemporal dementia (FTD), which overlaps with ALS/MND in a proportion of cases.

Because progression is variable, it is difficult to make precise predictions for any individual. A specialist or multidisciplinary care team is best placed to discuss what to expect based on a person’s specific situation.

Finding support after diagnosis

A diagnosis of ALS/MND affects not only the person diagnosed, but also family members and caregivers. Finding the right support early can make a significant difference.

The Alliance’s member associations provide support, information, and services to people living with ALS/MND and their families around the world. To find an association in your region, visit the Member Association directory.

Find a Member Association

Note: This page provides general information only. It is not a substitute for medical advice. Anyone with concerns about their symptoms or diagnosis should speak with a qualified healthcare professional.

Primary Sidebar

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Jean

    Jean
    jean

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Lee Millard, England

    Lee Millard, England

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Glen Elison, USA

    Glen Elison, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Mike Small, UK

    Mike Small, UK

  • Daniel Hare, USA

    Daniel Hare, USA

  • JP

    JP

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Purningam Jacob, India

    Purningam Jacob, India

  • Jason Goodman, USA

    Jason Goodman, USA

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Jon Newsome, USA

    Jon Newsome, USA

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Ian Gale, Australia

    Ian Gale, Australia

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Liam Dwyer, England

    Liam Dwyer, England

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login